CD8A and myeloid sarcoma: Rather, in correlation to the level of luminal MHC class I-restricted Ag presentation, recognition of their cognate Ag on the BBB will prohibit CD8+ T cell entry into the CNS and eventually lead to focal BBB breakdown as observed in MS.